Insider Transactions in Q3 2021 at Halozyme Therapeutics, Inc. (HALO)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2021
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
50,000
-4.3%
|
$2,100,000
$42.64 P/Share
|
|
Sep 07
2021
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.85%
|
$700,000
$14.66 P/Share
|
|
Sep 04
2021
|
Masaru Matsuda SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,412
-14.54%
|
$143,304
$42.22 P/Share
|
|
Sep 04
2021
|
Masaru Matsuda SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,883
+22.68%
|
-
|
|
Aug 25
2021
|
Jean Pierre Bizzari |
SELL
Open market or private sale
|
Direct |
35,000
-39.98%
|
$1,435,000
$41.01 P/Share
|
|
Aug 10
2021
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
50,000
-1.45%
|
$2,150,000
$43.14 P/Share
|
|
Aug 10
2021
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.85%
|
$700,000
$14.66 P/Share
|
|
Jul 15
2021
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,685
+8.98%
|
$88,110
$6.55 P/Share
|
|
Jul 06
2021
|
Helen Torley PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
50,000
-8.52%
|
$2,250,000
$45.97 P/Share
|
|
Jul 06
2021
|
Helen Torley PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+7.85%
|
$700,000
$14.66 P/Share
|
|
Jul 01
2021
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
40,315
-23.11%
|
$1,814,175
$45.7 P/Share
|
|
Jul 01
2021
|
Michael J. La Barre SVP, CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
40,315
+18.77%
|
$241,890
$6.55 P/Share
|